Healthy Skepticism Library
Items published in 2013
There are 69 items in the Healthy Skepticism Library that were published in 2013.
Page 1 of 1 pages
HSL20592
Wegwarth O, Gigerenzer G
Overdiagnosis and Overtreatment: Evaluation of What Physicians Tell Their Patients About Screening Harms
JAMA Internal Med 2013 Dec; 173:(22):2086-2087
http://archinte.jamanetwork.com/article.aspx?articleID=1754987
HSL20591
Schwitzer G
When doctors don’t discuss harms of screening tests with patients
Health New Review.org 2013 Oct 22
http://www.healthnewsreview.org/2013/10/when-doctors-dont-discuss-harms-of-screening-tests-with-patients/
HSL20593
Unreliable research: Trouble at the lab
The Economist 2013 Oct 19
HSL20585
Ubel PA, Abernethy AP, Zafar SY
Full Disclosure - Out-of-Pocket Costs as Side Effects
NEJM 2013 Oct 17; 369:
http://www.nejm.org/doi/full/10.1056/NEJMp1306826
HSL20586
Wen L
What Do You Know About Your Doctor?
Psychology Today 2013 Oct 15
http://www.psychologytoday.com/blog/the-doctor-is-listening/201310/what-do-you-know-about-your-doctor
HSL20587
Blumer C
Ethical Triage For Doctors
The Globe and Mail 2013 Oct 15
http://www.theglobalmail.org/blog/ethical-triage-for-doctors/710/
HSL20588
Bertens LCM, Broekhuizen BDL, Naaktgeboren CA, Rutten FH, Hoes AW, van Mourik Y, Moons KGM, Reitsma JB
Use of Expert Panels to Define the Reference Standard in Diagnostic Research: A Systematic Review of Published Methods and Reporting
PLoS Med 2013 Oct 15; 10:(10):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001531
HSL20589
Blumer C
Medical Ethics Under The Knife
The Global Mail 2013 Oct 9
http://www.theglobalmail.org/feature/medical-ethics-under-the-knife/707/
HSL20590
Arie S
Doctors’ groups are criticised for endorsing pro-industry guidelines
BMJ 2013 Oct 9; 347:
http://www.bmj.com/content/347/bmj.f6066
HSL20584
Taylor L
Serious side-effects warnings can increase drug sales: study
PharmaTimes 2013 Sep 24
http://www.pharmatimes.com/Article/13-09-24/Serious_side-effects_warnings_can_increase_drug_sales_study.aspx
HSL20583
Bowie C
Sales reps struggling with the new NHS environment
Pharma Times 2013 Aug 30
http://www.pharmatimes.com/Article/13-08-30/Sales_reps_struggling_with_the_new_NHS_environment.aspx
HSL20581
Burns M
Report profiles cardiologists for market insights
Pharmalive 2013 Aug 29
http://www.pharmalive.com/report-profiles-cardiologists-for-market-insights
HSL20580
Moynihan RN, Cooke GPE, Doust JA, Bero L, Hill S, Glasziou PP
Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United States
PLoS Med 2013 Aug 13;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001500
HSL20578
Cavicchi V
Defining the Audience: Customer-Centric Sales Strategies and Physician Segmentation
Cutting Edge Info 2013 July 24
http://www.cuttingedgeinfo.com/2013/defining-audience-customer-centric-sales-strategies-physician-segmentation/
HSL20575
Fern Tay H
Chinese police accuse GlaxoSmithKline of artificially inflating cost of medicine
PM : ABC Radio National 2013 July 180
http://www.abc.net.au/pm/content/2013/s3806244.htm
HSL20574
Yan A, Han Shih T
Shanghai travel agent's revenue surge led to arrests in GSK bribery case
South China Post 2013 July 16
http://www.scmp.com/news/china/article/1283207/glaxosmithkline-suspects-drug-bribery-probe-identified
HSL20573
Trans-Pacific trade agreement could choke off patient access to affordable generic medicines
Medicines Sans Frontiers 2013 July 15
http://www.msfaccess.org/about-us/media-room/press-releases/trans-pacific-trade-agreement-could-choke-patient-access
HSL20577
Nagarajan R
The patient doctor
The Times of India 2013 July 6
http://www.timescrest.com/coverstory/the-patient-doctor-10659
HSL20571
Burns M
Study unearths ‘surprising’ findings on doctors’ good publication practice views
Pharmalive 2013 Jun 26
http://www.pharmalive.com/study-unearths-‘surprising’-findings-on-doctors’-good-publication-practice-views
HSL20579
Wise J
Novartis found to be in breach of code over drug brochure
BMJ 2013 Jun 20; 346:
http://www.bmj.com/content/346/bmj.f4061
HSL20568
Davies E
Flu hype and pharma failures: patients deserve better
BMJ 2013 May 24; 346:
http://www.bmj.com/content/346/bmj.f3422
HSL20561
Eban K
The latest to claim fraud at generic Lipitor maker Ranbaxy: Its owners
CNN Money 2013 May 23
http://features.blogs.fortune.cnn.com/2013/05/23/ranbaxy-lipitor-fraud/
HSL20562
Harvey K, Voevodin M
Regulations around food-medicine products fail to protect consumers
The Conversation 2013 May 21
https://theconversation.com/regulations-around-food-medicine-products-fail-to-protect-consumers-14360
HSL20570
Davies E
Can Big Pharma put patients first?
BMJ 2013 May 21; 346:
http://www.bmj.com/content/346/bmj.f3285
HSL20560
Govt to regulate rates of 652 medicines; prices set to fall
Economic Times 2013 May 17
http://articles.economictimes.indiatimes.com/2013-05-17/news/39336744_1_essential-drugs-price-control-indian-pharmaceutical-alliance
HSL20569
Doshi P
Influenza: marketing vaccine by marketing disease
BMJ 2013 May 16; 346:
http://www.bmj.com/content/346/bmj.f3037
HSL20559
Tiefer L, Witczak K, Heath I
A call to challenge the 'Selling of Sickness'
BMJ 2013 May 14; 346:f2809
doi: http://dx.doi.org/10.1136/bmj.f2809
http://www.bmj.com/content/346/bmj.f2809
HSL20563
Corderoy A
Most pills and potions fail the test
The Sydney Morning Herald 2013 May 12
http://www.smh.com.au/national/health/most-pills-and-potions-fail-the-test-20130511-2jeji.html
HSL20564
Corderoy A
War of words on potions and pills continues
The Sydney Morning Herald 2013 May 12
http://www.smh.com.au/national/health/war-of-words-on-potions-and-pills-continues-20130511-2jely.html
HSL20558
Rome E
Big Pharma CEOs Rake in $1.57 Billion in Pay
The Huffington Post 2013 May 8
http://www.huffingtonpost.com/ethan-rome/big-pharma-ceo-pay_b_3236641.html
HSL20565
McCredie J
Jane McCredie: A drop of credibility
MJA InSight 2013 May 6;
https://www.mja.com.au/insight/2013/16/jane-mccredie-drop-credibility
HSL20566
Ed.
Exorbitant Prices for Leukemia Drugs
The New York Times 2013 May 1
http://www.nytimes.com/2013/05/02/opinion/exorbitant-prices-for-cancer-drugs.html?_r=0
HSL20551
How Big Pharma Is Killing Americans
Truthout 2013 Apr 29
http://truth-out.org/opinion/item/16071-how-big-pharma-is-killing-americans
HSL20531
Rosenberg M
6 New Ways Big Pharma Is Scheming to Make Billions at the Expense of Your Health
Alternet 2013 Apr 25
http://www.alternet.org/personal-health/6-new-ways-big-pharma-scheming-make-billions-expense-your-health?paging=off
HSL20532
J.D. Power study shows physicians still see reps as main influence
Pharmalive 2013 Apr 25
http://www.pharmalive.com/jd-power-and-associates-reports-that-relationship-marketing-still-matters-in-oncology-pharma-sales
HSL20530
US govt sues Novartis for health care fraud
The Indian Express 2013 Apr 24
http://m.indianexpress.com/news/us-govt-sues-novartis-for-health-care-fraud/1106948/
HSL20501
Indian Supreme Court Delivers Verdict in Novartis Case
Medicines Sans Frontiers 2013 Apr 1
http://www.msfaccess.org/about-us/media-room/press-releases/indian-supreme-court-delivers-verdict-novartis-case
HSL20495
Ed.
Getting Closer to a Fully Correctable and Connected Research Literature
PLoS Med 2013 Mar 26; 10:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001408?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plosmedicine%2FNewArticles+%28Ambra+-+Medicine+New+Articles%29
HSL20496
Ana J, KoehlmoosT, Smith R, Yan LL
Research Misconduct in Low- and Middle-Income Countries
PLoS Med 2013 Mar 26; 10:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001315
HSL20497
Resnik DB, Master Z
Policies and Initiatives Aimed at Addressing Research Misconduct in High-Income Countries
PLoS Med 2013 Mar 26; 10:(3):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001406?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plosmedicine%2FNewArticles+%28Ambra+-+Medicine+New+Articles%29
HSL20498
Svensson S, Menkes DB, Lexchin J
Surrogate Outcomes in Clinical Trials: A Cautionary Tale
JAMA 2013 Mar 25; (1-2 ):
http://archinte.jamanetwork.com/article.aspx?articleid=1672283
HSL20493
Sharp C
Key Opinion Leaders – A Fast and Furious Approach to Brand Recognition
eyeforpharma 2013 Mar 21
http://social.eyeforpharma.com/sales-marketing/key-opinion-leaders-mclaren-content-marketing-barcelona
HSL20462
Brauser D
Psychiatrists Top List of Big Pharma Payments Again
Medscape 2013 Mar 14;
http://www.medscape.com/viewarticle/780835
HSL20461
Kmietowicz Z
BMA follows Lancet in quitting group on collaboration between doctors and drug industry
BMJ 2013 Mar 8; 346:
http://dx.doi.org/10.1136/bmj.f1574
HSL20455
'Bayer’s Tonic' still on the Market
Coalition against Bayer Dangers 2013 Mar 5
www.CBGnetwork.org
HSL20458
Bramwell N
TGA reform delays slammed
Medical Observer 2013 Mar 5
http://www.medicalobserver.com.au/news/tga-reform-delays-slammed
HSL20492
Wood M
Sales Excellence in the Pharma Industry: An Interview with Hoffmann-La Roche’s Michael van Olm
eyeforpharma 2013 Mar 4
http://social.eyeforpharma.com/sales-marketing/sales-excellence-pharma-roche-michael-van-olm-interview
HSL20456
Cymbalta still tops in U.S. drug promotion list
Med Ad News 2013 Feb 28
http://blog.medadnews.com/index.php/2013/02/28/cymbalta-still-tops-in-u-s-drug-promotion-list/
HSL20457
Kaye B
Senate bill to ban pharma freebies
Medical Observer 2013 Feb 28
http://www.medicalobserver.com.au/news/senate-bill-to-ban-pharma-freebies
HSL20460
Blumer C, Seccombe M
Who’s Your Doctor Dining With? (And Why You Should Care)
The Global Mail 2013 Feb 28
http://powerhouse.theglobalmail.org/whos-your-doctor-dining-with-and-why-you-should-care/
HSL20459
Pirri C
Embracing CAM
MJA InSight 2013 Feb 25
http://www.mjainsight.com.au/view?post=carlo-pirri-embracing-cam&post_id=12270&cat=comment&mo=1
HSL20470
Burns M
Manhattan Research: Pharma widens target to new decision makers
Med Ad News 2013 Feb 11
http://blog.medadnews.com/index.php/2013/02/11/pharma-widens-target-to-new-decision-makers/
HSL20452
Kmietowicz Z
GSK backs campaign for disclosure of trial data
BMJ 2013 Feb 7; 346:
http://www.bmj.com/content/346/bmj.f819
HSL20453
Roehr B
Drug companies will have to report all payments to US doctors from March 2014
BMJ 2013 Feb 7; 346:
http://www.bmj.com/content/346/bmj.f826
HSL20451
Davis C
Is there a cure for corporate crime in the drug industry?
BMJ 2013 Feb 6; 346:
http://www.bmj.com/content/346/bmj.f755
HSL20454
Tucker ME
Drug companies lobby against generic versions of biologics
BMJ 2013 Feb 4; 346:
http://www.bmj.com/content/346/bmj.f740
HSL20450
Horton R
Offline: Falling out with pharma
The Lancet 2013 Feb 2; 381:(9864):358
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2960139-7/fulltext
HSL20449
Kanter J, Thomas K
European Officials Say Drug Makers Paid to Delay Generic Version
The New York Times 2013 Jan 31
http://www.nytimes.com/2013/02/01/business/global/eu-says-drug-makers-paid-to-delay-generic-version.html?smid=tw-nytimeshealth&seid=auto&_r=1&
HSL20481
Ed.
Getting More Generous with the Truth: Clinical Trial Reporting in 2013 and Beyond
PLoS Med 2013 Jan 29; 10:(1):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001379
HSL20482
Vedula SS, Li T, Dickersin K
Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
PLoS Med 2013 Jan 29; 10:(1):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001378
HSL20448
Doherty B
Drug companies 'using Indians as guinea pigs'
The Sydney Morning Herald 2013 Jan 27
http://www.smh.com.au/world/drug-companies-using-indians-as-guinea-pigs-20130126-2dduh.html?skin=text-only
HSL20447
Entry prices for new medications fall 35%
brasil.gov.br 2013 Jan 22
http://www.brasil.gov.br/news/history/2013/01/22/entry-prices-for-new-medications-fall-35/newsitem_view?set_language=en
HSL20471
Duijnhoven RG, Straus SMJM, Raine JM, de Boer A, Hoes AW, De Bruin ML
Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis
PLoS Med 2013;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001407
HSL20542
Lopert R, Gleeson D
The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines
The Journal of Law, Medicine & Ethics 2013; 41:(1):199–223
http://onlinelibrary.wiley.com/doi/10.1111/jlme.12014/abstract
HSL20572
Brougher J
Evergreening patents: The Indian Supreme Court rejects patenting of incremental improvements
Journal of Commerical Biotechnology 2013; 19:(3):
doi: http://dx.doi.org/10.5912/jcb614
http://commercialbiotechnology.com/index.php/jcb/article/view/614
HSL20576
Light DW
Risky Drugs: Why The FDA Cannot Be Trusted
Journal of Law, Medicine and Ethics 2013;
http://www.ethics.harvard.edu/lab/blog/312-risky-drugs
HSL20506
Stamatakis E, Weiler R, Ioannidis JP.
Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review.
Eur J Clin Invest 2013 25;
doi: 10.1111/eci.12074. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/23521369
HSL20567
Burns M
Report: Access rates to physicians decline
Pharmalive 2013
http://www.pharmalive.com/report-access-rates-to-physicians-declines
HSL20582
Burns M
HxP seeks out ways to better arm salesforces
PharmaLive 2013
http://www.pharmalive.com/hxp-seeks-out-ways-to-better-arm-salesforces
Page 1 of 1 pages
